Herombopag Olamine Tablets
Herombopag Olamine Tablets is a pharmaceutical drug with 8 clinical trials. Currently 2 active trials ongoing.
Success Metrics
Phase Distribution
Phase Distribution
2
Early Stage
5
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
0.0%
0 of 0 finished
0.0%
0 ended early
2
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Herombopag Treated T-DM1 Induced Platelet Reduction
A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma
Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study
A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP
A Multicentre Real-world Study of Heptapopal Ethanolamine Tablets in Concurrent/Sequential Radioimmunoinduced Thrombocytopenia
Clinical Trials (8)
Herombopag Treated T-DM1 Induced Platelet Reduction
A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma
Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study
A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP
A Multicentre Real-world Study of Heptapopal Ethanolamine Tablets in Concurrent/Sequential Radioimmunoinduced Thrombocytopenia
Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects.
Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects
An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLC
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8